Sachdev Amit
Vertex Pharmaceuticals Inc · EVP Chief Patient & Ext Af Off
Sachdev Amit is listed in filings as EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Feb 26, 2026, including sale activity. Recent filings connect the profile to Vertex Pharmaceuticals Inc (VRTX). The current snapshot covers public activity from Feb 12, 2025 to Feb 26, 2026. Reported amounts are shown as $897.8K to $9.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $9M19.7k shares | SellFeb 19, 2026 | $468.57 | $481.00 | |
| $6M11.7k shares | SellFeb 19, 2026 | $470.54 | $481.00 | |
| $5M10.3k shares | SellFeb 19, 2026 | $467.75 | $481.00 | |
| $3M7.2k shares | SellFeb 19, 2026 | $469.61 | $481.00 | |
| $2M4.2k shares | SellFeb 19, 2026 | $471.43 | $481.00 | |
| $1M2.7k shares | SellFeb 19, 2026 | $465.05 | $481.00 | |
| $861k1.8k shares | SellFeb 19, 2026 | $465.80 | $481.00 | |
| $427k920 shares | SellFeb 19, 2026 | $463.91 | $481.00 |